Steven Cohen's ATRC Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 604,380 shares of AtriCure, Inc. (ATRC) worth $16.91 M, representing 0.02% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in ATRC, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 604,380 shares. Largest reduction occurred in Q2 2025, reducing 558,348 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's AtriCure (ATRC) Holding Value Over Time
Track share changes against reported price movement
Quarterly AtriCure (ATRC) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +604,380 | New Buy | 604,380 | $27.98 |
| Q1 2026 | -277,924 | Sold Out | 0 | $0.00 |
| Q4 2025 | +277,924 | New Buy | 277,924 | $39.56 |
| Q2 2025 | -558,348 | Sold Out | 0 | $0.00 |
| Q1 2025 | +558,348 | New Buy | 558,348 | $32.26 |
| Q4 2023 | -4 | Sold Out | 0 | $0.00 |
| Q3 2023 | -183,496 | Reduce 100.00% | 4 | $43.75 |
| Q2 2023 | +68,281 | Add 59.26% | 183,500 | $49.36 |
| Q1 2023 | +115,219 | New Buy | 115,219 | $41.45 |
| Q3 2022 | -24,400 | Sold Out | 0 | $0.00 |
| Q2 2022 | -135,386 | Reduce 84.73% | 24,400 | $40.86 |
| Q1 2022 | +55,300 | Add 52.93% | 159,786 | $65.67 |
| Q4 2021 | +104,486 | New Buy | 104,486 | $69.53 |
| Q2 2020 | -135,498 | Sold Out | 0 | $0.00 |
| Q1 2020 | -125,630 | Reduce 48.11% | 135,498 | $33.59 |
| Q4 2019 | +153,606 | Add 142.86% | 261,128 | $32.51 |
| Q3 2019 | +107,522 | New Buy | 107,522 | $24.94 |
| Q4 2018 | -174,520 | Sold Out | 0 | $0.00 |
| Q3 2018 | +174,520 | New Buy | 174,520 | $35.03 |
| Q4 2017 | -18,500 | Sold Out | 0 | $0.00 |
| Q3 2017 | -118,796 | Reduce 86.53% | 18,500 | $22.38 |
| Q2 2017 | +137,296 | New Buy | 137,296 | $24.25 |
| Q1 2016 | -106,700 | Sold Out | 0 | $0.00 |
| Q4 2015 | +106,700 | New Buy | 106,700 | $22.44 |
| Q3 2014 | -300,000 | Sold Out | 0 | $0.00 |
| Q2 2014 | +300,000 | Add 0.00% | 300,000 | $18.38 |
Steven Cohen's AtriCure Investment FAQs
Steven Cohen first purchased AtriCure, Inc. (ATRC) in Q2 2014, acquiring 300,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held AtriCure, Inc. (ATRC) for 26 quarters since Q2 2014.
Steven Cohen's largest addition to AtriCure, Inc. (ATRC) was in Q2 2026, adding 604,380 shares worth $16.91 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 604,380 shares of AtriCure, Inc. (ATRC), valued at approximately $16.91 M.
As of the Q2 2026 filing, AtriCure, Inc. (ATRC) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in AtriCure, Inc. (ATRC) was 604,380 shares, as reported at the end of Q2 2026.